Published in Antiviral Res on December 26, 2012
Role of the microbiota in immunity and inflammation. Cell (2014) 3.43
Compartmentalized and systemic control of tissue immunity by commensals. Nat Immunol (2013) 1.60
The Pneumonia Virus of Mice (PVM) model of acute respiratory infection. Viruses (2012) 0.93
Probiotics in respiratory virus infections. Eur J Clin Microbiol Infect Dis (2014) 0.85
Immunobiotic Lactobacillus administered post-exposure averts the lethal sequelae of respiratory virus infection. Antiviral Res (2015) 0.83
B cells are not essential for Lactobacillus-mediated protection against lethal pneumovirus infection. J Immunol (2014) 0.83
Signaling via pattern recognition receptors NOD2 and TLR2 contributes to immunomodulatory control of lethal pneumovirus infection. Antiviral Res (2016) 0.80
The influence of the microbiota on the immune response to transplantation. Curr Opin Organ Transplant (2015) 0.79
Priming of the Respiratory Tract with Immunobiotic Lactobacillus plantarum Limits Infection of Alveolar Macrophages with Recombinant Pneumonia Virus of Mice (rK2-PVM). J Virol (2015) 0.78
Sustained inflammation and differential expression of interferons type I and III in PVM-infected interferon-gamma (IFNγ) gene-deleted mice. Virology (2014) 0.77
Eosinophil-associated ribonuclease 11 is a macrophage chemoattractant. J Biol Chem (2015) 0.77
"The microbiome and immune regulation after transplantation". Transplantation (2016) 0.75
Silkworm larvae plasma (SLP) assay for detection of bacteria: False positives secondary to inflammation in vivo. J Microbiol Methods (2016) 0.75
Respiratory Antiviral Immunity and Immunobiotics: Beneficial Effects on Inflammation-Coagulation Interaction during Influenza Virus Infection. Front Immunol (2016) 0.75
Immortalized MH-S cells lack defining features of primary alveolar macrophages and do not support mouse pneumovirus replication. Immunol Lett (2016) 0.75
Administration of immunobiotic Lactobacillus plantarum delays but does not prevent lethal pneumovirus infection in Rag1(-/-) mice. J Leukoc Biol (2017) 0.75
Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science (1993) 14.91
The burden of respiratory syncytial virus infection in young children. N Engl J Med (2009) 8.95
Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol (2007) 7.80
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet (2001) 5.25
Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol (2006) 4.55
Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev (2010) 3.31
Nontypeable Haemophilus influenzae: pathogenesis and prevention. Microbiol Mol Biol Rev (1998) 2.24
NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J Immunol (2008) 1.73
Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula. Appl Environ Microbiol (2006) 1.70
Nontypeable Haemophilus influenzae: understanding virulence and commensal behavior. Trends Microbiol (2007) 1.64
A review of palivizumab and emerging therapies for respiratory syncytial virus. Expert Opin Biol Ther (2011) 1.62
The role of neutrophils during mild and severe influenza virus infections of mice. PLoS One (2011) 1.61
Pneumonia virus of mice: severe respiratory infection in a natural host. Immunol Lett (2008) 1.58
Animal models of human respiratory syncytial virus disease. Am J Physiol Lung Cell Mol Physiol (2011) 1.57
Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. J Clin Invest (2011) 1.53
Augmented lung inflammation protects against influenza A pneumonia. PLoS One (2009) 1.47
Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice. Am J Respir Crit Care Med (2008) 1.44
Respiratory syncytial virus prevention and therapy: past, present, and future. Pediatr Pulmonol (2010) 1.43
Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani. Infect Immun (2007) 1.36
Inducible innate resistance of lung epithelium to infection. Annu Rev Physiol (2010) 1.34
Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases. Pediatr Infect Dis J (2008) 1.31
Regulation of epithelial immunity by IL-17 family cytokines. Trends Immunol (2012) 1.29
Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo. J Virol (2004) 1.28
Respiratory syncytial virus infection in elderly adults. Drugs Aging (2005) 1.26
Lactobacillus-mediated priming of the respiratory mucosa protects against lethal pneumovirus infection. J Immunol (2010) 1.26
Gammaherpesvirus modulation of mouse adenovirus type 1 pathogenesis. Virology (2008) 1.25
The impact of successive infections on the lung microenvironment. Immunology (2007) 1.21
Synergistic interactions of TLR2/6 and TLR9 induce a high level of resistance to lung infection in mice. J Immunol (2011) 1.16
Respiratory infections: do we ever recover? Proc Am Thorac Soc (2007) 1.11
Do viral infections mimic bacterial sepsis? The role of microvascular permeability: A review of mechanisms and methods. Antiviral Res (2011) 1.11
Peptidoglycan: a critical activator of the mammalian immune system during infection and homeostasis. Immunol Rev (2011) 1.11
The pattern recognition receptors Nod1 and Nod2 account for neutrophil recruitment to the lungs of mice infected with Legionella pneumophila. Microbes Infect (2010) 1.10
Rapid PCR-based procedure to identify lactic acid bacteria: application to six common Lactobacillus species. J Microbiol Methods (2001) 1.09
Postinfluenza bacterial pneumonia: host defenses gone awry. J Interferon Cytokine Res (2010) 1.09
Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents. J Virol (2003) 1.08
Cathepsin G and neutrophil elastase play critical and nonredundant roles in lung-protective immunity against Streptococcus pneumoniae in mice. Infect Immun (2011) 1.06
Effect of intranasal administration of Lactobacillus pentosus S-PT84 on influenza virus infection in mice. Int Immunopharmacol (2010) 1.05
Type I interferon response to extracellular bacteria in the airway epithelium. Trends Immunol (2011) 1.05
Effect of intranasal administration of Lactobacillus casei Shirota on influenza virus infection of upper respiratory tract in mice. Clin Diagn Lab Immunol (2001) 1.04
Nod2: a key regulator linking microbiota to intestinal mucosal immunity. J Mol Med (Berl) (2011) 1.01
Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses. Lett Appl Microbiol (2010) 0.99
Intranasal administration of live Lactobacillus species facilitates protection against influenza virus infection in mice. Antiviral Res (2011) 0.98
Inhaled innate immune ligands to prevent pneumonia. Br J Pharmacol (2011) 0.97
The Pneumonia Virus of Mice (PVM) model of acute respiratory infection. Viruses (2012) 0.93
Innate imprinting by the modified heat-labile toxin of Escherichia coli (LTK63) provides generic protection against lung infectious disease. J Immunol (2004) 0.93
Inflammatory responses to respiratory syncytial virus (RSV) infection and the development of immunomodulatory pharmacotherapeutics. Curr Med Chem (2012) 0.93
Regulatory role of suppressive motifs from commensal DNA. Mucosal Immunol (2012) 0.93
Bordetella pertussis infection exacerbates influenza virus infection through pertussis toxin-mediated suppression of innate immunity. PLoS One (2011) 0.92
The innate immune rheostat: influence on lung inflammatory disease and secondary bacterial pneumonia. Biochem Soc Trans (2009) 0.92
Attenuated Bordetella pertussis protects against highly pathogenic influenza A viruses by dampening the cytokine storm. J Virol (2010) 0.91
Retracted NOD2 signaling contributes to host defense in the lungs against Escherichia coli infection. Infect Immun (2012) 0.87
Muramyl dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infection. PLoS One (2012) 0.85
A silkworm larvae plasma test for detecting peptidoglycan in cerebrospinal fluid is useful for the diagnosis of bacterial meningitis. Microbiol Immunol (2003) 0.81
Probiotic genomic DNA reduces the production of pro-inflammatory cytokine tumor necrosis factor-alpha. FEMS Microbiol Lett (2012) 0.79
De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum (2002) 4.98
Eosinophils: biological properties and role in health and disease. Clin Exp Allergy (2008) 3.92
Adaptive evolution of a duplicated pancreatic ribonuclease gene in a leaf-eating monkey. Nat Genet (2002) 3.49
Eosinophils: changing perspectives in health and disease. Nat Rev Immunol (2012) 2.69
Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow. J Immunol (2008) 2.22
Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine. Clin Cancer Res (2006) 2.20
Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J Exp Med (2008) 2.04
Pasteurella multocida meningitis in newborns after incidental animal exposure. Pediatr Infect Dis J (2009) 1.89
Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity. Infect Immun (2006) 1.76
Expression of the secondary granule proteins major basic protein 1 (MBP-1) and eosinophil peroxidase (EPX) is required for eosinophilopoiesis in mice. Blood (2013) 1.72
Animal pneumoviruses: molecular genetics and pathogenesis. Clin Microbiol Rev (2004) 1.67
Pneumonia virus of mice: severe respiratory infection in a natural host. Immunol Lett (2008) 1.58
Animal models of human respiratory syncytial virus disease. Am J Physiol Lung Cell Mol Physiol (2011) 1.57
Activated mouse eosinophils protect against lethal respiratory virus infection. Blood (2013) 1.54
Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. Blood (2007) 1.52
Chemokine regulation of inflammation during acute viral infection. Curr Opin Allergy Clin Immunol (2003) 1.42
Schistosoma mansoni infection in eosinophil lineage-ablated mice. Blood (2006) 1.42
Mazzotti reaction after presumptive treatment for schistosomiasis and strongyloidiasis in a Liberian refugee. Pediatr Infect Dis J (2006) 1.39
Complementary advantageous substitutions in the evolution of an antiviral RNase of higher primates. Proc Natl Acad Sci U S A (2002) 1.36
Inflammatory responses to pneumovirus infection in IFN-alpha beta R gene-deleted mice. J Immunol (2005) 1.34
Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation. J Immunol (2004) 1.33
Respiratory dysfunction and proinflammatory chemokines in the pneumonia virus of mice (PVM) model of viral bronchiolitis. Virology (2006) 1.32
RNase 8, a novel RNase A superfamily ribonuclease expressed uniquely in placenta. Nucleic Acids Res (2002) 1.28
Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo. J Virol (2004) 1.28
Lactobacillus-mediated priming of the respiratory mucosa protects against lethal pneumovirus infection. J Immunol (2010) 1.26
Human RNase 7: a new cationic ribonuclease of the RNase A superfamily. Nucleic Acids Res (2003) 1.22
The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention. Pharmacol Ther (2005) 1.16
Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6. Blood (2009) 1.15
Differential expression of proinflammatory cytokine genes in vivo in response to pathogenic and nonpathogenic pneumovirus infections. J Infect Dis (2002) 1.13
Animal models for studying respiratory syncytial virus infection and its long term effects on lung function. Pediatr Infect Dis J (2004) 1.11
Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells. Blood (2003) 1.11
The RNase a superfamily: generation of diversity and innate host defense. Mol Divers (2006) 1.10
Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents. J Virol (2003) 1.08
Early-life viral infection and allergen exposure interact to induce an asthmatic phenotype in mice. Respir Res (2010) 1.07
IL-21 promotes the pathologic immune response to pneumovirus infection. J Immunol (2012) 1.06
Respiratory viruses and eosinophils: exploring the connections. Antiviral Res (2009) 1.06
Interferon-gamma coordinates CCL3-mediated neutrophil recruitment in vivo. BMC Immunol (2009) 1.06
Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice. Vaccine (2006) 1.06
Antigen profiles for the quantitative assessment of eosinophils in mouse tissues by flow cytometry. J Immunol Methods (2011) 1.02
Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptor. J Immunol (2010) 1.01
The mouse RNase 4 and RNase 5/ang 1 locus utilizes dual promoters for tissue-specific expression. Nucleic Acids Res (2005) 1.01
Plasmacytoid dendritic cells promote host defense against acute pneumovirus infection via the TLR7-MyD88-dependent signaling pathway. J Immunol (2011) 1.00
Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein. Biochemistry (2003) 0.98
Eosinophils from lineage-ablated Delta dblGATA bone marrow progenitors: the dblGATA enhancer in the promoter of GATA-1 is not essential for differentiation ex vivo. J Immunol (2007) 0.98
Gene microarray analysis reveals interleukin-5-dependent transcriptional targets in mouse bone marrow. Blood (2003) 0.97
Pulmonary eosinophils and their role in immunopathologic responses to formalin-inactivated pneumonia virus of mice. J Immunol (2009) 0.96
Diversifying selection of the tumor-growth promoter angiogenin in primate evolution. Mol Biol Evol (2002) 0.96
Novel inflammatory markers, clinical risk factors and virus type associated with severe respiratory syncytial virus infection. Pediatr Infect Dis J (2013) 0.96
Clinical features, adenovirus types, and local production of inflammatory mediators in adenovirus infections. Pediatr Infect Dis J (2009) 0.96
Efficient replication of pneumonia virus of mice (PVM) in a mouse macrophage cell line. Virol J (2007) 0.95
Mechanical ventilation enhances lung inflammation and caspase activity in a model of mouse pneumovirus infection. Am J Physiol Lung Cell Mol Physiol (2008) 0.94
The Pneumonia Virus of Mice (PVM) model of acute respiratory infection. Viruses (2012) 0.93
Evolution and function of leukocyte RNase A ribonucleases of the avian species, Gallus gallus. J Biol Chem (2006) 0.93
Eosinophilia and the seroprevalence of schistosomiasis and strongyloidiasis in newly arrived pediatric refugees: an examination of Centers for Disease Control and Prevention screening guidelines. J Pediatr (2010) 0.92
Targeting eosinophils in asthma. Curr Mol Med (2008) 0.91
KIT GNNK splice variants: expression in systemic mastocytosis and influence on the activating potential of the D816V mutation in mast cells. Exp Hematol (2013) 0.89
Unrecognized viral respiratory tract infections in premature infants during their birth hospitalization: a prospective surveillance study in two neonatal intensive care units. J Pediatr (2012) 0.89
IL-33 promotes eosinophilia in vivo and antagonizes IL-5-dependent eosinophil hematopoiesis ex vivo. Immunol Lett (2012) 0.88
Generation of eosinophils from unselected bone marrow progenitors: wild-type, TLR- and eosinophil-deficient mice. Open Immunol J (2009) 0.87
Canine pneumovirus replicates in mouse lung tissue and elicits inflammatory pathology. Virology (2011) 0.87